Sign in
4

Changes in Ownership

Emmaus Life Sciences, Inc. Filed Acc 0001615774-16-004862

Chief Executive Officer acquired 1,000,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Carpenter George C IV Chief Executive Officer 2016-04-05 Grant or award +1,000,000 2,390,799 D
Loading xslF345X03/s102984.xml…